For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Zonisamide | Initial dose was 100 mg/day, increased by 100 mg. The maximum dose was 600 mg/day. | None | None | 5 | 96 | 74 | 96 | View |
| Carbamazepine | Initial dose was 100mg/day, increased by 200mg every 1 week to 600mg/day. The maximum dose was 1200mg/day. | None | None | 9 | 104 | 70 | 104 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Worsening Insomnia | None | Psychiatric disorders | None | View |
| Depressive Mood | None | Psychiatric disorders | None | View |
| Right Shoulder Injury | None | General disorders | None | View |
| Visual Hallucination | None | Psychiatric disorders | None | View |
| Cervical Sprain | None | General disorders | None | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | None | View |
| Uterine Fibroid | None | Reproductive system and breast disorders | None | View |
| Sgot Increased | None | Investigations | None | View |
| Diabetic Ketoacidosis | None | Metabolism and nutrition disorders | None | View |
| Memory And Judgement Disturbance | None | Psychiatric disorders | None | View |
| Urticaria | None | Skin and subcutaneous tissue disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Dysuria | None | Renal and urinary disorders | None | View |
| Constipation | None | Gastrointestinal disorders | None | View |
| Sgpt Increased | None | Investigations | None | View |
| Mental Torpor | None | Psychiatric disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Mental Torpor | None | Psychiatric disorders | None | View |
| Gastrointestinal Pain | None | Gastrointestinal disorders | None | View |
| Pruritus | None | Skin and subcutaneous tissue disorders | None | View |
| Sleep Disorder | None | Psychiatric disorders | None | View |
| Fatigue | None | General disorders | None | View |
| Depression | None | Psychiatric disorders | None | View |
| Constipation | None | Gastrointestinal disorders | None | View |
| Dyspepsia | None | Gastrointestinal disorders | None | View |
| Dizziness | None | Nervous system disorders | None | View |
| Anorexia | None | Gastrointestinal disorders | None | View |
| Weight Decrease | None | Investigations | None | View |
| Drowsiness | None | Psychiatric disorders | None | View |
| Headache | None | Nervous system disorders | None | View |
| Nausea | None | Gastrointestinal disorders | None | View |
| Memory Impairment | None | Psychiatric disorders | None | View |
| Pyrexia | None | General disorders | None | View |
| Rash | None | Skin and subcutaneous tissue disorders | None | View |
| Diarrhoea | None | Gastrointestinal disorders | None | View |
| Urticaria | None | Skin and subcutaneous tissue disorders | None | View |